Who is sponsoring NCT05270473?

NCT05270473 is sponsored by Ain Shams Maternity Hospital.

What drugs are being tested in NCT05270473?

Interventions in NCT05270473: uterine compressive sutures.

What condition does NCT05270473 study?

NCT05270473 studies Bleeding in Cesarean Section.

Is NCT05270473 still recruiting?

NCT05270473 is currently completed. Last updated 23 February 2023.

Last reviewed 2023-02-23 · How we verify

NCT05270473

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Compression Sutures in Controlling Excessive Uterine Bleeding During Caesarean Section

Completed NA Last updated 23 February 2023

What this trial tests

NA trial testing uterine compressive sutures in Bleeding in Cesarean Section in 60 participants. Completed in 20 October 2022.

Timeline

20 March 2022

Primary endpoint
20 September 2022

20 October 2022

Quick facts

Lead sponsor	Ain Shams Maternity Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	60
Start date	20 March 2022
Primary completion	20 September 2022
Estimated completion	20 October 2022
Sites	2 locations across Egypt

Drugs / interventions tested

uterine compressive sutures

Conditions studied

Bleeding in Cesarean Section — all drugs for Bleeding in Cesarean Section →

Sponsor

Ain Shams Maternity Hospital

Who can join

Adults 16 to 42, female only, with Bleeding in Cesarean Section. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators found that B- Lynch suture is more effective than Nausicca suture in controlling excessive uterine bleeding during cesarean section and avoiding the need of hysterectomy. Also, the investigators found that B- lynch suture needs shorter procedure time with less blood loss compared to Nausicca suture. Consequently the investigators recommend the use of B-Lynch suture as a compressive uterine suture to control excessive uterine bleeding during cesarean section and avoid the need of hysterectomy. As a result of this study the investigators recommend further studies to compare different uterine compressive suture to verify the most effective uterine compressive suture.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams Maternity Hospital trials

Trials by the same sponsor.

NCT07514078 — Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer · NA · not yet recruiting
NCT07308977 — Practice of Assisted Vaginal Birth in Egypt · not yet recruiting
NCT06935422 — Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complic · recruiting
NCT06524700 — Pectopexy Autologous Vs Mesh · NA · active not recruiting
NCT07247851 — Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05270473 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams Maternity Hospital
Last refreshed: 23 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05270473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing